# Lobe Sciences Ltd. (LOBEF)

> Healthcare · CA · Reports in CAD

Fundamental indicators from Sponda, adjusted for inflation.

[HTML version](https://sponda.capital/en/LOBEF/fundamentals)

## Annual figures

| Year | Revenue (M) | Net Inc. (M) | FCF (M) | Debt (M) | Equity (M) |
| --- | --- | --- | --- | --- | --- |
| 2026 | $ 0 | $ -3.23M | $ -3.34M | $ 338.6K | $ 1.89M |
| 2025 | $ 0 | $ -4.43M | $ -1.42M | $ 273.2K | $ 2.35M |
| 2024 | $ 208.2K | $ -4.50M | $ -471.1K | $ 1.75M | $ -3.11M |
| 2023 | $ 872.2K | $ -4.88M | $ -1.78M | $ 332.6K | $ -160.1K |
| 2022 | $ 0 | $ -13.15M | $ -2.93M | N/A | $ 445.7K |
| 2021 | $ 206.0K | $ -11.02M | $ -5.75M | N/A | $ 11.29M |
| 2020 | $ 1.06M | $ -4.11M | $ -1.46M | $ 302.0K | $ 12.07M |
| 2019 | $ 931.8K | $ -50.5K | $ -1.63M | $ 0 | $ 6.19M |
| 2018 | $ 0 | $ -69.0K | $ -47.6K | $ 0 | $ -12.9K |
| 2017 | $ 0 | $ -70.3K | $ -55.3K | $ 0 | $ 43.4K |
| 2016 | $ 0 | $ -200.3K | $ -59.8K | $ 0 | $ 52.3K |
| 2015 | $ 0 | $ -91.9K | $ -91.0K | $ 0 | $ 208.8K |
| 2014 | $ 0 | $ -153.7K | $ -197.9K | $ 0 | $ 272.6K |
| 2013 | $ 0 | $ -150.6K | $ -70.2K | $ 0 | $ 389.1K |
| 2012 | $ 0 | $ -225.2K | $ -215.4K | $ 0 | $ 494.9K |
| 2011 | $ 0 | $ -6.9K | N/A | N/A | N/A |

Columns not available in this view: annualPriceMultiples, dividends. They require live market data and are shown on the HTML page instead.

## Leverage and liquidity

| Indicator | Value |
| --- | --- |
| Gross Debt / Eq | 0.18 |
| Liabilities / Eq | 1.23 |
| Current Ratio | 2.38 |

## Other views

- [Metrics](https://sponda.capital/en/LOBEF.md)
- [Charts](https://sponda.capital/en/LOBEF/charts.md)
- [Compare](https://sponda.capital/en/LOBEF/compare.md)
- [Indicator definitions](https://sponda.capital/en/screener.md)

Data as of 2026-08-29.